Drug Profile
KFA 1411
Latest Information Update: 11 Dec 2006
Price :
$50
*
At a glance
- Originator Kissei Pharmaceutical
- Class Antithrombotics
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 12 Jan 1999 New profile
- 12 Jan 1999 Preclinical development for Thrombosis in Japan (Unknown route)